In eastern Democratic Republic of Congo, an Ebola outbreak is reshaping life, with fear spreading faster than information and hospitals turning into places of urgent containment rather than care.
Discover how healthcare organizations are moving from early experimentation to broader AI adoption, connecting clinical improvements to financial impact.
The Food and Drug Administration (FDA) this week approved the first new sunscreen filter in more than two decades, sparking industry wide excitement. And while this ingredient will be new to the U.S., it's far from new to the market internationally. The FDA broke a 27-year dry spell on Tuesday when it added bemotrizinol, sold under the brand name PARSOL®...
Paul Markovich, president and CEO of Ascendiun, shared his ideas for bringing down healthcare costs, including digital health records and changing how healthcare is paid for. The post Paul Markovich’s 4 Ideas to Reduce Healthcare Costs appeared first on MedCity News .
(MedPage Today) -- CHICAGO -- Few men prescribed testosterone therapy received guideline-concordant diagnostic testing for androgen deficiency, and some received therapy despite contraindications, a retrospective chart review indicated. In a...
(MedPage Today) -- CHICAGO -- One in 12 patients with incident hypertension screened positive for primary aldosteronism, suggesting expanded screening may boost detection, according to a real-world cohort study. Among 2.5 million adults with...
(MedPage Today) -- "By the actions of the ADA, we've actually got millions of people to think about it." -- Steven Kahn, MBChB, editor-in-chief of Diabetes Care, on being kicked out of the American Diabetes Association (ADA) meeting after distributing...
(MedPage Today) -- CHICAGO -- Diabetes was linked with an increased risk of death among transplant recipients of four major organs, with pre-existing and new-onset diabetes both implicated, a comprehensive analysis of four types of solid-organ...
Rocket Pharmaceuticals received the rare pediatric disease priority review voucher with the accelerated FDA approval for Kresladi in March. The non-dilutive capital from the voucher’s sale will support a pipeline that includes a gene therapy in pivotal clinical testing for the rare genetic disorder Danon disease. The post Rocket Pharma Reaps $180M From Sale of FDA Drug Review Fast Pass appeared first on MedCity News .
The industry needs a framework that can translate clinical nuance into a consistent, trusted representation across systems and use cases. The post In the Age of AI, Interoperability Isn’t Enough: Why Healthcare Needs Shared Understanding, Not Just Shared Data appeared first on MedCity News .